Andere talen MYND Life Sciences Inc.

Aandelen

MYND

CA62857B1094

Beurs gesloten - Canadian Securities Exchange Andere beurzen 15:30:00 17-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,03 ^CAD	0,00%		+50,00%	-25,00%

21/03	MYND Life Sciences Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 januari 2024	CI
04/03	MYND Life Sciences Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 oktober 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	21/03
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	04/03
MYND Life Sciences Inc. Appoints Laurie Bakke as an Independent Non-Executive Director	30/01
MYND Life Sciences Announces New Director & Update on the Proposed Merger with Cava Healthcare Inc.	30/01
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. to Executive Chairman from the Role of CEO	06/12
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. from the Role of CEO to Executive Chairman	06/12
MYND Life Sciences Inc. Appoints Mr. John Campbell as Chief Executive Officer	06/12
MYND Life Sciences Inc. Appoints John Campbell as President	06/12
MYND Life Sciences Inc. Announces the Appointment of Mr. John Campbell as President and Chief Executive Officer	06/12
Dr. Lyle Oberg Appointment as Board Chair of Alberta Health Services and Executive Chair of MYND Life Sciences	04/12
MYND Life Sciences Inc. Announces Non-Binding LOI to enable merger with Cava Healthcare Inc.	26-10-23
MYND Life Sciences Inc. entered into a non-binding letter of intent to acquire Cava Healthcare Inc.	25-10-23
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	19-09-23
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	29-06-23
MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	05-05-23
MYND Life Sciences Inc. Auditor Raises 'Going Concern' Doubt	28-04-23
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	28-04-23
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	28-09-22
VMYND Lifesciencs Inc. cancelled the acquisition of Tidal Psychedelics.	29-06-22
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	23-06-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen MYND Life Sciences Inc.

Aandelen

MYND

CA62857B1094

Andere talen

Filters